|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Primary infertility and oral contraceptive steroid use. |
| Bagwell MA; Coker AL; Thompson SJ; Baker ER; Addy CL |
| FERTILITY AND STERILITY. 1995 Jun;63(6):1161-6. |
| Researchers compared data on 419 nulligravid US women diagnosed with primary infertility (no conception during 24 |
| consecutive months of unprotected intercourse) with data on 2120 fertile women to examine the relationship between |
| use of combined monophasic oral contraceptives (OCs) and primary infertility. All cases had documented |
| reproductive histories from menarche to menopause for contraceptive methods before infertility. Controls were more |
| likely than infertile women to have used OCs (14.2% vs. 9.07%; unadjusted odds ratio [OR] = 0.6) and to have used |
| OCs longer (33.6 vs. 30.1 months; OR = 0.6). Infertile women were just as likely as fertile women to have used high- |
| estrogen-dose OCs (i.e., >50 mcg) (5.28% vs. 8.52%). Fertile women were more likely than infertile women to have |
| used barrier methods (41.8% vs. 17.2%; OR = 0.29). When the researchers adjusted for education and barrier method |
| use, infertile women were still less likely to have used OCs than fertile women, especially women who were 20 years |
| old at first conception or infertility (adjusted OR [AOR] = 0.27) (AOR = 0.68 for older women). Both high- and low- |
| estrogen-dose OCs were associated with a reduced risk of primary infertility (AOR = 0.48 for <or= 50 mcg and 0.4 for |
| >50 mcg). These results suggest that combined OC use reduces the risk of primary infertility, especially among |
| younger women, regardless of duration of use or estrogen dose. (PubHealth.info Document ID: CONT2T 3016-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Primary infertility and oral contraceptive steroid use.", |
| is(are) Bagwell MA; Coker AL; Thompson SJ; Baker ER; Addy CL. The source of this article is "FERTILITY AND |
| STERILITY. 1995 Jun;63(6):1161-6.". This article was published in 1995 in English language(s). (PubHealth.info® |
| Document ID: CONT2T 3016-06. All rights reserved with PubHealth.info) PIN: 8016 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |